Cargando…
Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC
BACKGROUND: There have been reports of increased glutamate pyruvate transaminase 2 (GPT2) expression in certain cancers including breast cancer. Although the role of GPT2 as a metabolic enzyme is well understood in breast cancer progression, little is known about the other roles of GPT2, especially...
Autores principales: | Cui, Mingqing, Peng, Jiawei, Zhou, Yuanyuan, Wang, Xixi, Cui, Daxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363803/ https://www.ncbi.nlm.nih.gov/pubmed/37287397 http://dx.doi.org/10.1111/1759-7714.14984 |
Ejemplares similares
-
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple‐negative breast cancer via NF‐κB activation
por: Lim, Yvonne Xinyi, et al.
Publicado: (2021) -
miR-224 targets BTRC and promotes cell migration and invasion in colorectal cancer
por: Zheng, Qi, et al.
Publicado: (2020) -
TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling
por: Zhang, Baozhu, et al.
Publicado: (2018) -
EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC
por: Yan, Qijia, et al.
Publicado: (2015) -
LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)